Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 9Unspecified Adult Solid Tumor, Protocol Specific 2Sarcoma 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostatic Diseases 1Pancreatic Neoplasms 1Pain 1Non-squamous Non-small Cell Lung Cancer 1Neoplasms, Glandular and Epithelial 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Genital Neoplasms, Male 1Genital Diseases, Male 1Gallbladder Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms, Male 1Bile Duct Neoplasms 1Advanced Solid Tumors 1Adenocarcinoma 1

Interventions

tusamitamab ravtansine 1ixabepilone 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Non-squamous Non-small Cell Lung Cancer × ixabepilone × Clear all
NCT01057212 2015-09-07

Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Providence Health & Services

Phase 2 Terminated
6 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡